A Study to Analyze the Incidence, Risk Factors and the Treatment Outcomes in Retinopathy of Prematurity in a Tertiary Care Setup - Case Study
Asian Journal of Pregnancy and Childbirth · pp. 175–178 · Published 8 Sep 2020
10.9734/ajpcb/2020/v3i123Abstract
Aim: To study the association between the incidence, risk factors and treatment outcomes in retinopathy of prematurity. Methodology: A longitudinal observational study was done among 70 babies who fulfilled the criteria for ROP screening at a tertiary care center. Results: Out of the 70 babies that were screened at our hospital, 25 babies developed some stage of ROP with 10 babies developing Type 1 ROP. It was noted that the mean birth weight, mean gestational age and the duration of oxygen therapy was significantly associated with the development of ROP (P= 0.045,P<0.001 and P<0.001 respectively). Of the 25 babies with ROP, zone 3 was involved in 14 babies and zone 2 was involved in 11 babies.7 babies had stage 1,10 had stage 2 and 8 babies had stage 3. Of the 25 babies with ROP, 12 babies required treatment with laser photocoagulation and all the babies showed regression of ROP following treatment. Conclusion: Birth weight less than 1.70 kg, gestational age <32 weeks and oxygen therapy were associated with the development of ROP and ROP regressed with laser treatment.
Cited by 0
No indexed citations yet.
Related research
- Comparison of Ocular and Developmental Outcomes in Laser-and Bevacizumab-treated Infants with Retinopathy of Prematurity — shares topic coverage
- Recognition and Prevention of Visual Loss Due to Retinopathy of Prematurity in High Risk Twin Infant Pairs: A Case Series with a Multi-specialty Approach — shares topic coverage
- Prevalence and Risk Factors of Retinopathy of Prematurity (ROP): A Cross-Sectional Study — shares topic coverage
- Demographics and Clinical Patterns of Retinopathy of Prematurity at the University of Teaching Hospitals, Women and Newborn Hospital — shares topic coverage
- Clinical and Risk Factor Profile of Infants Treated with Bevacizumab or Nd: YAG Laser for Retinopathy of Prematurity — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.